Passage Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Passage Bio and other ETFs, options, and stocks.About PASG
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options.
CEOWilliam Chou
CEOWilliam Chou
Employees60
Employees60
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2017
Founded2017
Employees60
Employees60
PASG Key Statistics
Market cap28.58M
Market cap28.58M
Price-Earnings ratio-0.65
Price-Earnings ratio-0.65
Dividend yield—
Dividend yield—
Average volume60.88K
Average volume60.88K
High today$9.70
High today$9.70
Low today$8.82
Low today$8.82
Open price$9.00
Open price$9.00
Volume51.95K
Volume51.95K
52 Week high$20.20
52 Week high$20.20
52 Week low$5.12
52 Week low$5.12
Stock Snapshot
The current Passage Bio(PASG) stock price is $9.16, with a market capitalization of 28.58M. The stock trades at a price-to-earnings (P/E) ratio of -0.65.
As of 2025-12-17, Passage Bio(PASG) stock has fluctuated between $8.82 and $9.70. The current price stands at $9.16, placing the stock +3.9% above today's low and -5.6% off the high.
Passage Bio(PASG) shares are trading with a volume of 51.95K, against a daily average of 60.88K.
During the past year, Passage Bio(PASG) stock moved between $5.12 at its lowest and $20.20 at its peak.
During the past year, Passage Bio(PASG) stock moved between $5.12 at its lowest and $20.20 at its peak.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own PASG. This list is generated using Robinhood data, and it’s not a recommendation.